SYS | | r040596 |
LBL | | ^^^^^naa^^22^^^^^^^^450^ |
005 | | 20130619105651.3 |
100 | | $a 20070226a2006 m y0sloc0103 ba |
101 | 0- | $a eng $d eng |
102 | | $a SK |
200 | 1- | $a Expression and prognostic significance of cathepsin L in early cutaneous malignant melanoma $f B. Štabuc ... [et al.] |
215 | | $c obr., tab. |
320 | | $a Res. angl. |
320 | | $a Bibliogr. odkazy |
463 | -1 | $1 001 sllk_un_cat*sg000148_2006_006_003 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 53, no. 3 (2006), s. 259-262 $1 210 $a Bratislava $c VEDA, vydavateľstvo Slovenskej akadémie vied |
541 | 1- | $a Expresia a prognostická hodnota katepsínu L u skorého malígneho kožného melanómu $z slo |
606 | 1- | $a melanóm $x diagnostika $x patológia $2 mesh $3 sllk_un_auth*d008545 $9 . |
606 | 1- | $a katepsíny $x analýza $2 mesh $3 sllk_un_auth*d002403 $9 . |
606 | 1- | $a prognóza $2 mesh $3 sllk_un_auth*d011379 $9 . |
606 | 2- | $3 sllk_un_auth*d014408 $a biomarkery nádorové $x analýza $9 . $2 mesh |
606 | 2- | $a nádory kože $x enzymológia $x patológia $2 mesh $3 sllk_un_auth*d012878 $9 . |
606 | 2- | $a ELISA $x využitie $2 mesh $3 sllk_un_auth*d004797 $9 . |
610 | 2- | $a melanóm malígny |
610 | 2- | $a faktory prognostické |
610 | 2- | $a katepsín L |
675 | | $a 616.5-006.81.04 $v 2. $z slo |
701 | -1 | $a Štabuc $b B. $3 sllk_un_auth*p0053462 $4 070 $p Division of Internal Medicine, University Medical Centre Ljubljana, Slovenia |
701 | -1 | $a Mrevlje $b Ž. $3 sllk_un_auth*p0047159 $4 070 $p Division of Internal Medicine, University Medical Centre Ljubljana, Slovenia |
701 | -1 | $a Markovič $b J. $3 sllk_un_auth*p0047160 $4 070 $p Department of Anaesthesiology and Intensive Therapy, University Medical Centre Ljubljana, Slovenia |
701 | -1 | $a Štabuc-Šilih $b M. $3 sllk_un_auth*p0047161 $4 070 $p Eye Clinic, University Medical Centre Ljubljana, Slovenia |
801 | -0 | $a SK $b BA006 $c 20070226 $g AACR2 |